IGC Pharma Inc (IGC)
0.353
-0.04
(-9.70%)
USD |
NYAM |
Sep 22, 15:11
IGC Pharma Enterprise Value: 19.27M for Sept. 21, 2023
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 21, 2023 | 19.27M |
| September 20, 2023 | 19.40M |
| September 19, 2023 | 19.34M |
| September 18, 2023 | 20.54M |
| September 15, 2023 | 21.77M |
| September 14, 2023 | 21.43M |
| September 13, 2023 | 22.24M |
| September 12, 2023 | 21.81M |
| September 11, 2023 | 22.99M |
| September 08, 2023 | 19.20M |
| September 07, 2023 | 17.71M |
| September 06, 2023 | 17.07M |
| September 05, 2023 | 17.77M |
| September 01, 2023 | 16.58M |
| August 31, 2023 | 16.83M |
| August 30, 2023 | 15.66M |
| August 29, 2023 | 15.20M |
| August 28, 2023 | 15.43M |
| August 25, 2023 | 15.12M |
| August 24, 2023 | 14.90M |
| August 23, 2023 | 14.90M |
| August 22, 2023 | 15.10M |
| August 21, 2023 | 16.10M |
| August 18, 2023 | 16.04M |
| August 17, 2023 | 16.52M |
| Date | Value |
|---|---|
| August 16, 2023 | 16.52M |
| August 15, 2023 | 16.52M |
| August 14, 2023 | 17.30M |
| August 11, 2023 | 17.63M |
| August 10, 2023 | 17.28M |
| August 09, 2023 | 16.52M |
| August 08, 2023 | 17.36M |
| August 07, 2023 | 17.11M |
| August 04, 2023 | 17.71M |
| August 03, 2023 | 17.60M |
| August 02, 2023 | 17.11M |
| August 01, 2023 | 17.17M |
| July 31, 2023 | 15.98M |
| July 28, 2023 | 15.90M |
| July 27, 2023 | 15.51M |
| July 26, 2023 | 16.27M |
| July 25, 2023 | 16.25M |
| July 24, 2023 | 15.98M |
| July 21, 2023 | 16.13M |
| July 20, 2023 | 16.24M |
| July 19, 2023 | 16.34M |
| July 18, 2023 | 16.87M |
| July 17, 2023 | 16.93M |
| July 14, 2023 | 17.60M |
| July 13, 2023 | 18.89M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-15.88M
Minimum
Dec 31 2018
440.84M
Maximum
Oct 02 2018
34.23M
Average
21.16M
Median
Aug 12 2019
Enterprise Value Benchmarks
| Rite Aid Corp | 3.234B |
| Accolade Inc | 804.25M |
| CEL-SCI Corp | 52.52M |
| AIM ImmunoTech Inc | 0.7561M |
| NovaBay Pharmaceuticals Inc | 0.728M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.075M |
| Revenue (Quarterly) | 0.555M |
| Total Expenses (Quarterly) | 2.694M |
| EPS Diluted (Quarterly) | -0.04 |
| Gross Profit Margin (Quarterly) | 45.95% |
| Profit Margin (Quarterly) | -373.9% |
| Earnings Yield | -59.49% |
| Normalized Earnings Yield | -59.49 |